Nucleic acids polymeric backbone carboxy-mimicker derivatives inhibiting human cytomegalovirus 1. In vitro microbicidal effect

Antibiotiki i Khimioterapiya

Volumn 52, Issue 11-12, 2007, Pages 8-13

  Serbin, A V ^a   Karaseva, E N ^a   Fedorova, N E ^a   Pavlova, M V ^a   Klimova, E V ^a   Leontyeva, M V ^a   Kushch, A A ^a  

^a NONE

Author keywords

Adamantane; Antiviral inhibitor; Herpes virus; HIV; Human cytomegalovirus; Membranotropic modification; Microbicide; Norbornane; Polyanionic mimicker of nucleic acids; Sulfate

Indexed keywords

DRYOBALANOPS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS;

ADAMANTANE; ANION; ANTIVIRUS AGENT; CARBOXYLIC ACID; NORBORNANE DERIVATIVE; NUCLEIC ACID; POLYMER; SULFONIC ACID DERIVATIVE;

ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOMEGALOVIRUS; DRUG EFFECT; HUMAN; MOLECULAR MIMICRY; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ADAMANTANE; ANIONS; ANTIVIRAL AGENTS; CARBOXYLIC ACIDS; CELL SURVIVAL; CELLS, CULTURED; CYTOMEGALOVIRUS; HUMANS; MOLECULAR MIMICRY; NORBORNANES; NUCLEIC ACIDS; POLYMERS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS;

EID: 58949103877     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Emery V. C., Hassan-Walker A. F. Focus on new drugs in development against human cytomegalovirus. Drugs 2002; 62: 13: 1853-1858.
2. Bonnet F., Lewden C., May T. et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis 2005; 37: 6-7: 482-487.
3. Wohl D. A., Zeng D., Stewart P. et al. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent anti-retroviral therapies. J Acquir Immune Defic Syndr 2005; 38: 5: 538-544.
4. Russian source
5. Barinsky I. F., Krentsel B. A., Gribencha S. V. et al. Furan-maleic anhydride copolymers and their potential uses in the chemotherapy of viral infections. Sov Med Rev, E: Virology Reviews 1991; 4: 79-102.
6. Stotskaya L. L., Serbin A. V. Antiviral macromolecular therapeutic systems (MTS): principles and methods of design. Antivir Res 1993; 20: 1: 183.
7. Russian source
8. Russian source
9. Russian source
10. Russian source
11. Boukrinskaia, A. G., Serbin, A. V., Bogdan, O. P. et al. Polymeric adamantane analogues. US Pat 5880154A 1999.
12. Burshtein M. E., Serbin A. V., Khakhulina T. V., et al. Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents. Antivir Res 1999; 41: 3: 135-144
13. Serbin A. V., Klimochkin Yu. N., Boukrinskaya A. G. et al. Polymeric redesign of adamantane, norbornane and azidothymidine related antiviral drug. Ibid; 2002; 53: 3: 50.
14. Russian source
15. Russian source
16. Shukla D., Spear P. G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Investig 2001; 108: 503-510.
17. Russian source
18. Landolfo S., Gariglio M., Gribaudo G., et al. The human cytomegalovirus. Pharmacology & Therapeutics 2003; 98: 269-297.
19. De Clercq E. Strategies in the design of antiviral drugs. Nature Rev Drug Disc 2002; 1: 13-25.
20. Shukla D. A novel role for 3-O-sulfated heparin sulfate in herpes simplex virus 1 entry. Cell 1999; 99: 13-22.